Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Conference Poster
type: Class

Continuant
type: Class

Entity
type: Class

1999
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

RDF description of Genotypic resistance among HIV infected patients treated with protease inhibitors - http://research.umh.es/vivo/pub/comunicacion/22250
type: Document
rights: termsOfUse
date: 2026-08-29T09:25:51
publisher: Genotypic resistance among HIV infected patients treated with protease inhibitors

Genotypic resistance among HIV infected patients treated with protease inhibitors
type: Thing
related by: AutorExt:38547_1999-Comunicación:22250
related by: AutorExt:38544_1999-Comunicación:22250
related by: AutorExt:38543_1999-Comunicación:22250
related by: AutorExt:38549_1999-Comunicación:22250
type: Continuant
type: Conference Poster
date time value: 22250 pubdate
type: Generically Dependent Continuant
related by: AutorExt:38546_1999-Comunicación:22250
ARG_2000028: 22250 vcard
most specific type: Conference Poster
related by: Autor:35232-Comunicación:22250
type: Entity
type: Congress communication
type: Information Content Entity
type: Document
related by: AutorExt:38545_1999-Comunicación:22250
most specific type: Congress communication
most specific type: 1999
type: Anualidad
type: 1999
RO_0002353: 6th European Conference on Clinical Aspects and Treatment of HIV-infcetion
related by: AutorExt:38548_1999-Comunicación:22250
related by: AutorExt:38542_1999-Comunicación:22250
related by: AutorExt:38541_1999-Comunicación:22250

AutorExt:38547_1999-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors

AutorExt:38544_1999-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors

AutorExt:38543_1999-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors

AutorExt:38549_1999-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors

AutorExt:38546_1999-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors

Autor:35232-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors

AutorExt:38545_1999-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors

6th European Conference on Clinical Aspects and Treatment of HIV-infcetion
type: Anualidad
type: Thing
RO_0002234: Genotypic resistance among HIV infected patients treated with protease inhibitors
type: Conference
type: Event
type: 1999
type: BFO_0000003
type: Entity
type: BFO_0000015

AutorExt:38548_1999-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors

AutorExt:38542_1999-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors

AutorExt:38541_1999-Comunicación:22250
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Genotypic resistance among HIV infected patients treated with protease inhibitors